EPS Bio Technology Corp. (TPEX:4183)
Taiwan
· Delayed Price · Currency is TWD 14.10
-0.10 (-0.70%)
Apr 29, 2026, 1:30 PM CST
EPS Bio Technology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 123.08 | 128.94 | 195.29 | 178.66 | 203.42 | Upgrade
|
| Cash & Short-Term Investments | 123.08 | 128.94 | 195.29 | 178.66 | 203.42 | Upgrade
|
| Cash Growth | -4.55% | -33.97% | 9.31% | -12.17% | -8.32% | Upgrade
|
| Accounts Receivable | 150.35 | 149.8 | 92.09 | 78.81 | 101.23 | Upgrade
|
| Other Receivables | 5.98 | 4.88 | 2.97 | 2.27 | 2.78 | Upgrade
|
| Receivables | 156.33 | 154.67 | 95.05 | 81.08 | 104.01 | Upgrade
|
| Inventory | 73.24 | 81.06 | 72.67 | 86.45 | 81.56 | Upgrade
|
| Prepaid Expenses | - | 3.15 | 3.18 | 1.54 | 4.06 | Upgrade
|
| Other Current Assets | 2.82 | 0.17 | 0.15 | 0.06 | 0.05 | Upgrade
|
| Total Current Assets | 355.47 | 368 | 366.33 | 347.77 | 393.1 | Upgrade
|
| Property, Plant & Equipment | 169.51 | 167.86 | 163.14 | 172.32 | 173.57 | Upgrade
|
| Other Intangible Assets | 2.97 | 1.84 | 1.96 | 3.64 | 5.41 | Upgrade
|
| Long-Term Deferred Tax Assets | 2.19 | 1.59 | 3.38 | 1.85 | 2.38 | Upgrade
|
| Other Long-Term Assets | 3.1 | 2.61 | 8.36 | 2.18 | 3 | Upgrade
|
| Total Assets | 533.25 | 541.9 | 543.16 | 527.76 | 577.45 | Upgrade
|
| Accounts Payable | 72.73 | 80.64 | 74.54 | 58.31 | 81.38 | Upgrade
|
| Accrued Expenses | - | 25.02 | 27.02 | 26.33 | 26.88 | Upgrade
|
| Short-Term Debt | 40 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 2.59 | 2.55 | 2.52 | 2.54 | Upgrade
|
| Current Portion of Leases | 3.09 | 3.16 | 3.14 | 3.08 | 3.01 | Upgrade
|
| Current Income Taxes Payable | - | - | 7.28 | 6.65 | 8.96 | Upgrade
|
| Current Unearned Revenue | 8.54 | 13.19 | 3.79 | 1.6 | 29.29 | Upgrade
|
| Other Current Liabilities | 30.25 | 5.26 | 6.71 | 4.83 | 5.12 | Upgrade
|
| Total Current Liabilities | 154.62 | 129.85 | 125.03 | 103.32 | 157.17 | Upgrade
|
| Long-Term Debt | 7.76 | 10.4 | 12.98 | 15.52 | 18.02 | Upgrade
|
| Long-Term Leases | 87.26 | 93.99 | 97.15 | 100.28 | 102.91 | Upgrade
|
| Long-Term Unearned Revenue | 1.62 | 2.35 | 1.78 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.88 | 0.76 | 0.18 | 0.28 | 0.08 | Upgrade
|
| Total Liabilities | 252.14 | 237.34 | 237.13 | 219.41 | 278.18 | Upgrade
|
| Common Stock | 238 | 238 | 238 | 238 | 238 | Upgrade
|
| Additional Paid-In Capital | 31.6 | 31.6 | 31.6 | 31.6 | 31.6 | Upgrade
|
| Retained Earnings | 11.51 | 34.95 | 36.44 | 38.76 | 29.67 | Upgrade
|
| Shareholders' Equity | 281.11 | 304.55 | 306.04 | 308.36 | 299.27 | Upgrade
|
| Total Liabilities & Equity | 533.25 | 541.9 | 543.16 | 527.76 | 577.45 | Upgrade
|
| Total Debt | 138.11 | 110.14 | 115.82 | 121.4 | 126.47 | Upgrade
|
| Net Cash (Debt) | -15.03 | 18.81 | 79.47 | 57.26 | 76.95 | Upgrade
|
| Net Cash Growth | - | -76.34% | 38.80% | -25.60% | -14.45% | Upgrade
|
| Net Cash Per Share | -0.63 | 0.79 | 3.33 | 2.40 | 3.22 | Upgrade
|
| Filing Date Shares Outstanding | 23.95 | 23.8 | 23.8 | 23.8 | 23.8 | Upgrade
|
| Total Common Shares Outstanding | 23.95 | 23.8 | 23.8 | 23.8 | 23.8 | Upgrade
|
| Working Capital | 200.86 | 238.15 | 241.3 | 244.45 | 235.93 | Upgrade
|
| Book Value Per Share | 11.74 | 12.80 | 12.86 | 12.96 | 12.57 | Upgrade
|
| Tangible Book Value | 278.14 | 302.71 | 304.08 | 304.72 | 293.86 | Upgrade
|
| Tangible Book Value Per Share | 11.62 | 12.72 | 12.78 | 12.80 | 12.35 | Upgrade
|
| Buildings | - | 67.87 | 67.87 | 68.54 | 68.86 | Upgrade
|
| Machinery | - | 45.01 | 39.21 | 49.02 | 50.26 | Upgrade
|
| Construction In Progress | - | 2.35 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.